Supporting brain tumor research
Andreas Zimprich died of a brain tumor at the age of 48. His parents Marianne and Egon Zimprich founded the Andreas Zimprich Foundation in his memory together with the German Cancer Research Center.
The founders from Heilbronn want to promote research in the field of neuro-oncology: Patients with glioma should have a better chance of successful treatment than their son in the future. The foundation has been committed to researching innovative therapies for brain tumors since 2010.
Support brain tumor research: With a donation to the Andreas Zimprich Foundation, you can promote the development of new treatment methods. You can also support the Andreas Zimprich Foundation by making an endowment. Please contact us if you would like to do this.
David Hausmann, winner of the 2023 prize, researched calcium communication in the cellular networks of glioblastoma in his dissertation. This revealed well-connected pacemaker cells whose targeted inhibition with a drug already approved for humans slowed brain tumor growth in the mouse model and may represent a novel therapeutic option against glioblastomas.
Dr. Milena Pertz, neuropsychologist at the Department of Neurology at the University Hospital Knappschaftskrankenhaus Bochum, was awarded the Andreas Zimprich Prize 2021 for her dissertation "Assessment of cognitive and sociocognitive functions after diagnosis and therapy of a primary brain tumor", which was completed with top marks in mid-2021 at the Ruhr University Bochum.
Erik Jung was awarded the Andreas Zimprich Prize 2019. The prizewinner works as a doctor in the Department of Neurology at Heidelberg University Hospital and as a scientist specializing in glioma biology at the German Cancer Research Center. In his dissertation, Erik Jung investigated novel therapeutic approaches to malignant gliomas and was thus able to contribute to further research into brain tumors in the spirit of the Andreas Zimprich Foundation.
In 2017, the Andreas Zimprich Prize went to Christoph Geisenberger. He received the award for his research into the biological properties of glioblastomas that are associated with long-term survival. He carried out his work at the Neurosurgery Clinic at Heidelberg University Hospital.
The photo shows the 2017 prizewinner (left) together with other award-winning scientists at the award ceremony at the German Cancer Research Center.
The first prize winner was Lukas Bunse, physician and scientist in the Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology at the DKFZ and Heidelberg University Hospital. In his doctoral thesis, Lukas Bunse worked on the development of a vaccine against brain tumors.
The photo shows the 2015 award winner (center) together with the DKFZ Scientific Director Prof. Michael Boutros (far left), the laudator Prof. Wolfgang Wick (second from right) and the brother and father (far right) of the foundation's namesake.